Transaldolase 1
Transaldolase 1 is a protein that in humans is encoded by the TALDO1 gene. [1]
Function
Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway providing ribose-5-phosphate for nucleic acid synthesis and NADPH for lipid biosynthesis. This pathway can also maintain glutathione at a reduced state and thus protect sulfhydryl groups and cellular integrity from oxygen radicals. The functional gene of transaldolase 1 is located on chromosome 11 and a pseudogene is identified on chromosome 1 but there are conflicting map locations. The second and third exon of this gene were developed by insertion of a retrotransposable element. This gene is thought to be involved in multiple sclerosis. [provided by RefSeq, Jul 2008].
References
- ↑ “Entrez Gene: Transaldolase 1”. Retrieved 2017-10-19.
Further reading
- Grossman CE, Qian Y, Banki K, Perl A (2004). “ZNF143 mediates basal and tissue-specific expression of human transaldolase”. J. Biol. Chem. 279 (13): 12190–205. doi:10.1074/jbc.M307039200. PMID 14702349.
- Huang JB, Espinoza J, Romero R, Petty HR (2005). “Transaldolase is part of a supramolecular complex containing glucose-6-phosphate dehydrogenase in human neutrophils that undergoes retrograde trafficking during pregnancy”. Metab. Clin. Exp. 54 (8): 1027–33. doi:10.1016/j.metabol.2005.03.005. PMID 16092052.
- Valayannopoulos V, Verhoeven NM, Mention K, Salomons GS, Sommelet D, Gonzales M, Touati G, de Lonlay P, Jakobs C, Saudubray JM (2006). “Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease”. J. Pediatr. 149 (5): 713–7. doi:10.1016/j.jpeds.2006.08.016. PMID 17095351.
- Silberstein M, Landon MR, Wang YE, Perl A, Vajda S (2006). “Computational methods for functional site identification suggest a substrate access channel in transaldolase”. Genome Inform. 17 (1): 13–22. PMID 17503352.
- Wamelink MM, Smith DE, Jansen EE, Verhoeven NM, Struys EA, Jakobs C (2007). “Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine”. J. Inherit. Metab. Dis. 30 (5): 735–42. doi:10.1007/s10545-007-0590-2. PMID 17603756.
- Wamelink MM, Struys EA, Salomons GS, Fowler D, Jakobs C, Clayton PT (2008). “Transaldolase deficiency in a two-year-old boy with cirrhosis”. Mol. Genet. Metab. 94 (2): 255–8. doi:10.1016/j.ymgme.2008.01.011. PMID 18331807.
- Qian Y, Banerjee S, Grossman CE, Amidon W, Nagy G, Barcza M, Niland B, Karp DR, Middleton FA, Banki K, Perl A (2008). “Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing”. Biochem. J. 415 (1): 123–34. doi:10.1042/BJ20080722. PMID 18498245.
- Schneider S, Sandalova T, Schneider G, Sprenger GA, Samland AK (2008). “Replacement of a phenylalanine by a tyrosine in the active site confers fructose-6-phosphate aldolase activity to the transaldolase of Escherichia coli and human origin”. J. Biol. Chem. 283 (44): 30064–72. doi:10.1074/jbc.M803184200. PMC 2662071. PMID 18687684.
- Basta PV, Bensen JT, Tse CK, Perou CM, Sullivan PF, Olshan AF (2008). “Genetic variation in Transaldolase 1 and risk of squamous cell carcinoma of the head and neck”. Cancer Detect. Prev. 32 (3): 200–8. doi:10.1016/j.cdp.2008.08.008. PMC 2614275. PMID 18805652.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH